Researchers at the Kennedy Institute have developed a new computational framework that allows simultaneous analysis of gene ...

The firm is using single-cell, multiomics analysis to probe tumor samples from very long-term cancer survivors for keys to defeat the disease.

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many ...

Cure51 and Assistance Publique – Hôpitaux de Paris have partnered to identify biomarkers for long-term survival in pancreatic cancer.

Parse’s chromatin accessibility technology leverages a novel approach with advantages over existing methods such as ATAC-seq ...

Why do women's brains fare better in aging than men's? A study found that the second, 'silent' X chromosome turns on in the ...

Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future ...

Genomics , a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the ...

Genomics announced that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived ...

That's what makes a card like the Capital One Venture Rewards Credit Card such a precious commodity, with its simplicity in redeeming miles and a number of valuable airline and hotel transfer partners ...